FXA-27287-84335
3 vaccinations
11 coded responses
35 check-ins
11 free-text entries
7 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 201 / VA
- Registered
- 2021-01-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-12
Registered in v-safe
-
2021-01-12
Dose 1 — Pfizer-BioNTech
-
2021-01-12
Survey response — day 0, dose 1MedDRA: Anaphylactic reaction — Feeling: Poor · Site: Pain, Redness · Headache, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: AnaphylaxisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-12
Report sent to call center — day 0, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-15
Survey response — days 1–6 daily, dose 1MedDRA: Anaphylactic reaction — Feeling: Poor · Site: Pain, Redness · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I had anaphylaxis to the vaccine on Tuesday and still suffering from thatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-15
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-16
Survey response — days 1–6 daily, dose 1MedDRA: Anaphylactic reaction — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Extended feelings due to the anaphylaxis. Still taking benadryl, Famotidine, and AlbuterolMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-16
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-17
Survey response — days 1–6 daily, dose 1MedDRA: Unevaluable event — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Almost had anaphylaxis sequelaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-17
Report sent to call center — days 1–6 daily, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-19
Health check-in — day 7, dose 1Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitAdult check-in
-
2021-01-19
Report sent to call center — day 7, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-01-26
- 2021-02-04
-
2021-02-09
Survey response — day 28, dose 1MedDRA: Nasal congestion — Feeling: GoodFree text: Nasal congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-16
Survey response — day 35, dose 1MedDRA: Diarrhoea — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesFree text: DiarrheaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-24
- 2021-02-24
-
2021-02-24
Call successfulReported to VAERS voluntarily prior to GDIT contact
- 2021-04-13
-
2021-07-13
Survey response — 6 months, dose 1MedDRA: Sinusitis — Feeling: Good · Be unable to work or attend schoolFree text: A sinus infectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2022-01-13
Survey response — 12 months, dose 1MedDRA: Eczema, Gastrointestinal viral infection, Pre-existing disease — Feeling: Fair · Be unable to work or attend schoolFree text: I have had several episodes of gi viruses and flare ups of eczema. I also miscarried a pregnancy.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-16
Dose 2 — Novavax
- 2022-09-21
- 2022-09-22
- 2022-09-23
- 2022-09-30
-
2022-10-07
Survey response — day 21, dose 2MedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I got covidMedDRA releases: 2024-11 · check-in free text available
-
2022-10-07
Report sent to call center — day 21, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-10-10
- 2022-10-14
-
2022-10-21
Dose 3 — Novavax
- 2022-10-21
- 2022-10-21
- 2022-10-22
-
2022-10-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2022-10-24
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-10-25
-
2022-10-26
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Joint pains, Fatigue or tirednessAdult check-in
- 2022-10-27
-
2022-10-28
Survey response — day 7, dose 3MedDRA: Rhinorrhoea — Feeling: Fair · Site: Pain · Joint pains, Fatigue or tirednessFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-11-04
-
2022-11-11
Survey response — day 21, dose 3MedDRA: Bronchospasm, Chest pain, Cough, Fatigue, Laryngitis, Office visit — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Chest pain, continued fatigue, continued cough and laryngitis, bronchospasms · Healthcare visit (other): In person visit with PCPMedDRA releases: 2024-11 · check-in free text available
-
2022-11-11
Report sent to call center — day 21, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-11-14
- 2022-11-14
- 2022-11-18
- 2022-11-25
- 2022-12-02
- 2023-01-20
- 2023-04-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-12 | Pfizer-BioNTech | |
| 2 | 2022-09-16 | Novavax | No |
| 3 | 2022-10-21 | Novavax | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-12 | Successful 2021-02-24 |
Reported to VAERS voluntarily prior to GDIT contact |
| 2021-01-15 | Successful | Reported to VAERS voluntarily prior to GDIT contact |
| 2021-01-16 | Successful | Reported to VAERS voluntarily prior to GDIT contact |
| 2021-01-17 | Successful | Reported to VAERS voluntarily prior to GDIT contact |
| 2021-01-19 | Successful | Reported to VAERS voluntarily prior to GDIT contact |
| 2022-10-07 | Unsuccessful | |
| 2022-11-11 | Unsuccessful |
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Anaphylaxis
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): I had anaphylaxis to the vaccine on Tuesday and still suffering from that
Systemic reaction (other): Extended feelings due to the anaphylaxis. Still taking benadryl, Famotidine, and Albuterol
Systemic reaction (other): Almost had anaphylaxis sequela
Release 3 — day 28, dose 1
Symptoms: Nasal congestion
Release 4 — day 35, dose 1
Symptoms: Diarrhea
Release 9 — 6 months, dose 1
Symptoms: A sinus infection
Release 10 — 12 months, dose 1
Symptoms: I have had several episodes of gi viruses and flare ups of eczema. I also miscarried a pregnancy.
Release 12 — day 21, dose 2
Symptoms: I got covid
Release 12 — day 7, dose 3
Systemic reaction (other): Runny nose
Release 12 — day 21, dose 3
Symptoms: Chest pain, continued fatigue, continued cough and laryngitis, bronchospasms
Healthcare visit (other): In person visit with PCP
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Bronchospasm | · | · | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Eczema | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Gastrointestinal viral infection | · | · | ✓ |
| SD | Laryngitis | · | · | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Sinusitis | ✓ | ✓ | ✓ |
| SRO | Anaphylactic reaction | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release